{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:29:52Z","timestamp":1787765392120,"version":"build-2784847793"},"reference-count":41,"publisher":"Open Exploration Publishing","issue":"3","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/doi.org\/10.37349\/Open_Exploration_Crossmark_Policy"}],"funder":[{"DOI":"10.13039\/100005640","name":"Flight Attendant Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007161","name":"Boston University","doi-asserted-by":"publisher","award":["1UL1TR001430"],"award-info":[{"award-number":["1UL1TR001430"]}],"id":[{"id":"10.13039\/100007161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["psychoceramics.labs.crossref.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Aims: Epigenetic variation of DNA methylation of the mu-opioid receptor gene (OPRM1) has been identified in the blood and saliva of individuals with opioid use disorder (OUD) and infants with neonatal opioid withdrawal syndrome (NOWS). It is unknown whether epigenetic variation in OPRM1 exists within placental tissue in women with OUD and whether it is associated with NOWS outcomes. In this pilot study, we aimed to 1) examine the association between placental OPRM1 DNA methylation levels and NOWS outcomes, and 2) compare OPRM1 methylation levels in opioid-exposed versus non-exposed control placentas.\nMethods: Placental tissue was collected from eligible opioid (n = 64) and control (n = 29) women after delivery. Placental DNA was isolated and methylation levels at six cytosine-phosphate-guanine (CpG) sites within the OPRM1 promoter were quantified. Methylation levels were evaluated for associations with infant NOWS outcome measures: need for pharmacologic treatment, length of hospital stay (LOS), morphine treatment days, and treatment with two medications. Regression models were created and adjusted for clinical co-variates. Methylation levels between opioid and controls placentas were also compared.\nResults: The primary opioid exposures were methadone and buprenorphine. Forty-nine (76.6%) of the opioid-exposed infants required pharmacologic treatment, 10 (15.6%) two medications, and average LOS for all opioid-exposed infants was 16.5 (standard deviation 9.7) days. There were no significant associations between OPRM1 DNA methylation levels in the six CpG sites and any NOWS outcome measures. No significant differences were found in methylation levels between the opioid and control samples.\nConclusions: No significant associations were found between OPRM1 placental DNA methylation levels and NOWS severity in this pilot cohort. In addition, no significant differences were seen in OPRM1 methylation in opioid versus control placentas. Future association studies examining methylation levels on a genome-wide level are warranted.<\/jats:p>","DOI":"10.37349\/emed.2020.00009","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T02:19:28Z","timestamp":1591323568000},"page":"124-135","update-policy":"https:\/\/doi.org\/10.37349\/open_exploration_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study"],"prefix":"10.37349","volume":"1","author":[{"given":"Elisha M.","family":"Wachman","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Boston Medical Center, Boston, MA 02119, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston Medical Center, Boston, MA 02119, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna C.","family":"Isley","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston Medical Center, Boston, MA 02119, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Boateng","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob A.","family":"Beierle","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Hansbury","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston Medical Center, Boston, MA 02119, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camron","family":"Bryant","sequence":"additional","affiliation":[{"name":"Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Boston University School of Medicine, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21850","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004-2014. Pediatrics. 2018;141:e20173520.","DOI":"10.1542\/peds.2017-3520"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Tolia VN, Patrick SW, Bennett MM, Murthy K, Sousa J, Smith PB, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med. 2015;372:2118-26.","DOI":"10.1056\/nejmsa1500439"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Patrick SW, Davis MM, Lehman CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35:667.","DOI":"10.1038\/jp.2015.63"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis. Am J Epidemiol. 2014;180:673-86.","DOI":"10.1093\/aje\/kwu190"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Wachman EM, Warden AH, Thomas Z, Thomas-Lewis JA, Shrestha H, Nikita FNU, et al. Impact of psychiatric medication co-exposure on neonatal abstinence syndrome severity. Drug Alcohol Depend. 2018;192:45-50.","DOI":"10.1016\/j.drugalcdep.2018.07.024"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Jones HE, Heil SH, Tuten M, Chisolm MS, Foster JM, O\u2019Grady KE, et al. Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes. Drug Alcohol Depend. 2013;131:271-7.","DOI":"10.1016\/j.drugalcdep.2012.11.019"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Wachman EM, Schiff DM, Silverstein M. Neonatal abstinence syndrome: advances in diagnosis and treatment. JAMA. 2018;319:1362-74.","DOI":"10.1001\/jama.2018.2640"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Wachman EM, Farrer LA. The genetics and epigenetics of neonatal abstinence syndrome. Semin Fetal Neonatal Med. 2019;24:105-10.","DOI":"10.1016\/j.siny.2019.01.002"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Wachman EM, Hayes MJ, Sherva R, Brown MS, Shrestha H, Logan BA, et al. Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity. Am J Addict. 2017;26:42-9.","DOI":"10.1111\/ajad.12483"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Wachman EM, Hayes MJ, Brown MS, Paul J, Harvey-Wilkes K, Terrin N, et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA. 2013;309:1821-7.","DOI":"10.1001\/jama.2013.3411"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Wachman EM, Hayes MJ, Sherva R, Brown MS, Davis JM, Farrer LA, et al. Variations in opioid receptor genes in neonatal abstinence syndrome. Drug Alcohol Depend. 2015;155:253-9.","DOI":"10.1016\/j.drugalcdep.2015.07.001"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Wachman EM, Hayes MJ, Lester BM, Terrin N, Brown MS, Nielsen DA, et al. Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. J Pediatr. 2014;165:472-8.","DOI":"10.1016\/j.jpeds.2014.05.040"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Wachman EM, Hayes MJ, Shrestha H, Nikita FNU, Nolin A, Hoyo L, et al. Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads. Genes Brain Behav. 2018;17:e12476.","DOI":"10.1111\/gbb.12476"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Cardenas A, Lutz SM, Everson TM, Perron P, Bouchard L, Hivert M-F. Mediation by placental DNA methylation of the association of prenatal maternal smoking and birth weight. Am J Epidemiol. 2019;188:1878-86.","DOI":"10.1093\/aje\/kwz184"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Novakovic B, Saffery R. The ever growing complexity of placental epigenetics - role in adverse pregnancy outcomes and fetal programming. Placenta. 2012;33:959-70.","DOI":"10.1016\/j.placenta.2012.10.003"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Januar V, Desoye G, Novakovic B, Cvitic S, Saffery R. Epigenetic regulation of human placental function and pregnancy outcome: considerations for causal inference. Am J Obstet Gynecol. 2015;213 Suppl 4:S182-96.","DOI":"10.1016\/j.ajog.2015.07.011"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Vlahos A, Mansell T, Saffery R, Novakovic B. Human placental methylome in the interplay of adverse placental health, environmental exposure, and pregnancy outcome. PLoS Genet. 2019;15:e1008236.","DOI":"10.1371\/journal.pgen.1008236"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Palma-Gudiel H, C\u00f3rdova-Palomera A, Eixarch E, Deuschle M, Fa\u00f1an\u00e1s L. Maternal psychosocial stress during pregnancy alters the epigenetic signature of the glucocorticoid receptor gene promoter in their offspring: a meta-analysis. Epigenetics. 2015;10:893-902.","DOI":"10.1080\/15592294.2015.1088630"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Appleton AA, Murphy MA, Koestler DC, Lesseur C, Paquette AG, Padbury JF, et al. Prenatal programming of infant neurobehaviour in a healthy population. Paediatr Perinat Epidemiol. 2016;30:367-75.","DOI":"10.1111\/ppe.12294"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"van Otterdijk SD, Binder AM, Michels KB. Locus-specific DNA methylation in the placenta is associated with levels of pro-inflammatory proteins in cord blood and they are both independently affected by maternal smoking during pregnancy. Epigenetics. 2017;12:875-85.","DOI":"10.1080\/15592294.2017.1361592"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Barua S, Junaid MA. Lifestyle, pregnancy and epigenetic effects. Epigenomics. 2015;7:85-102.","DOI":"10.2217\/epi.14.71"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Conradt E, Fei M, LaGasse L, Tronick E, Guerin D, Gorman D, et al. Prenatal predictors of infant self-regulation: the contributions of placental DNA methylation of NR3C1 and neuroendocrine activity. Front Behav Neurosci. 2015;9:130.","DOI":"10.3389\/fnbeh.2015.00130"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Paquette AG, Lester BM, Lesseur C, Armstrong DA, Guerin DJ, Appleton AA, et al. Placental epigenetic patterning of glucocorticoid response genes is associated with infant neurodevelopment. Epigenomics. 2015;7:767-79.","DOI":"10.2217\/epi.15.28"},{"key":"ref23","unstructured":"Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2:141-58."},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, et al. Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial. JAMA Pediatr. 2018;172:741-8.","DOI":"10.1001\/jamapediatrics.2018.1307"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Wachman EM, Saia K, Humphreys R, Minear S, Combs G, Philipp BL. Revision of breastfeeding guidelines in the setting of maternal opioid use disorder: one institution\u2019s experience. J Hum Lact. 2016;32:382-7.","DOI":"10.1177\/0890334415613823"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125:279-84.","DOI":"10.1016\/s0166-4328(01)00297-2"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363:2320-31.","DOI":"10.1056\/nejmoa1005359"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Saia K, Bagley SM, Wachman EM, Patel PP, Nadas MD, Brogly SB. Prenatal treatment for opioid dependency: observations from a large inner-city clinic. Addict Sci Clin Pract. 2017;12:5.","DOI":"10.1186\/s13722-016-0070-9"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Levran O, Yuferov V, Kreek MJ. The genetics of the opioid system and specific drug addictions. Hum Genet. 2012;131:823-42.","DOI":"10.1007\/s00439-012-1172-4"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Nielsen DA, Yuferov V, Hamon S, Jackson C, Ho A, Ott J, et al. Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology. 2009;34:867-73.","DOI":"10.1038\/npp.2008.108"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Nielsen DA, Utrankar A, Reyes JA, Simons DD, Kosten TR. Epigenetics of drug abuse: predisposition or response. Pharmacogenomics. 2012;13:1149-60.","DOI":"10.2217\/pgs.12.94"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Zhang H, Herman AI, Kranzler HR, Anton RF, Simen AA, Gelernter J. Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence. J Hum Genet. 2012;57:670-5.","DOI":"10.1038\/jhg.2012.98"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Ebrahimi G, Asadikaram G, Akbari H, Nematollahi MH, Abolhassani M, Shahabinejad G, et al. Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder. Am J Drug Alcohol Abuse. 2018;44:193-9.","DOI":"10.1080\/00952990.2016.1275659"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Chidambaran V, Gang Y, Pilipenko V, Ashton M, Ding L. Systematic review and meta-analysis of genetic risk of developing chronic postsurgical pain. J Pain. 2019;[Epub ahead of print].","DOI":"10.1016\/j.jpain.2019.05.008"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Banik A, Kandilya D, Ramya S, St\u00fcnkel W, Chong YS, Dheen ST. Maternal factors that induce epigenetic changes contribute to neurological disorders in offspring. Genes. 2017;8:150.","DOI":"10.3390\/genes8060150"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Conradt E, Lester BM, Appleton AA, Armstrong DA, Marsit CJ. The roles of DNA methylation of NR3C1 and 11\u03b2-HSD2 and exposure to maternal mood disorder in utero on newborn neurobehavior. Epigenetics. 2013;8:1321-9.","DOI":"10.4161\/epi.26634"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Paquette AG, Lester BM, Koestler DC, Lesseur C, Armstrong DA, Marsit CJ. Placental FKBP5 genetic and epigenetic variation is associated with infant neurobehavioral outcomes in the RICHS cohort. PLoS One. 2014;9:e104913.","DOI":"10.1371\/journal.pone.0104913"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Zhang H, Herman AI, Kranzler HR, Anton RF, Zhao H, Zheng W, et al. Array-based profiling of DNA methylation changes associated with alcohol dependence. Alcohol Clin Exp Res. 2013;37 Suppl 1:E108-15.","DOI":"10.1111\/j.1530-0277.2012.01928.x"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Spence JP, Liang T, Foroud T, Lo D, Carr LG. Expression profiling and QTL analysis: a powerful complementary strategy in drug abuse research. Addict Biol. 2005;10:47-51.","DOI":"10.1080\/13556210412331308958"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Xu H, Wang F, Liu Y, Yu Y, Gelernter J, Zhang H. Sex-biased methylome and transcriptome in human prefrontal cortex. Hum Mol Genet. 2014;23:1260-70.","DOI":"10.1093\/hmg\/ddt516"}],"container-title":["Exploration of Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.explorationpub.com\/Journals\/em\/Article\/10019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T07:34:45Z","timestamp":1598859285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.explorationpub.com\/Journals\/em\/Article\/10019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,6,29]]}},"URL":"https:\/\/doi.org\/10.37349\/emed.2020.00009","archive":["Portico"],"relation":{},"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"2020-3-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-5-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-6-5","order":2,"name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}